Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Quantum-Si Inc Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "BRANFORD, Conn. -- -- Aug. 7, 2023 -- Quantum-Si Incorporated , The Protein Sequencing Company TM , today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights ● Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum TM instruments. ● Strengthened the Board of Directors with the addition of Scott Mendel and Jack Kenny. ● Since May 2023, strengthened the Executive Management team with the additions of Jeff Keyes as Chief Financial Officer and Johan Denecke as Senior Vice President, Operations ● Published five new applications notes since May 2023 demonstrating the use of Quantum-Si’s next-generation protein sequencing across various applications in support of b..."
05/11/2023 8-K Quarterly results
Docs: "GUILFORD, Conn. -- -- May 11, 2023 -- Quantum-Si Incorporated , The Protein Sequencing Company TM , today announced financial results for the first quarter ended March 31, 2023. Recent Highlights ● Revenue was $254,000 on orders of $449,000 in the first quarter of 2023. ● Gross margin was 48.8% in the first quarter of 2023. ● Appointed Jeff Keyes as Chief Financial Officer effective May 15, 2023. ● Strengthened commercial, operations, and development teams with several key executive appointments to help advance commercialization operations. ● Attended Association of Biomolecular Resource Facilities Annual Meeting and exhibited four new application notes. 2023 Financial Outlook ● The Company expects non-GAAP operating expense growth to be approximately fl..."
03/06/2023 8-K Quarterly results
11/07/2022 8-K Quarterly results
Docs: "GUILFORD, Conn. -- -- Nov. 07, 2022 -- Quantum-Si Incorporated , a life sciences company commercializing the first next-generation, single-molecule protein sequencing platform, today announced financial results for the third quarter ending September 30, 2022."
08/08/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
Docs: "GUILFORD, Conn.-- --Feb. 28, 2022-- Quantum-Si Incorporated , a life sciences company commercializing single molecule protein sequencing, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021. Recent Business Highlights ● Announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of the Board, as Interim Chief Executive Officer. ● Formed a new Scientific Advisory Board whose goal will be to identify high-impact, routine applications for single molecule protein sequencing across research, clinical, and diagnostics. ● Established list prices for our protein sequencing platform in anticipation of commercial launch in 2022. ● Shared a technical manuscript on bioRxiv providing an overview of Time Domain S..."
11/10/2021 8-K Quarterly results
Docs: "Press Release"
08/16/2021 8-K Quarterly results
Docs: "Quantum-Si Reports Second Quarter 2021 Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy